The renin-angiotensin-aldosterone system (RAAS) is currently one of the main involved in the mechanism of pressure reduction and renoprotection with several randomized controlled studies showing the reno-protective potential of angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin II (ARB) in nephropathies of almost any etiology. Here, ACE is linked to Nephropathy.